Cheek cell fatty acids reflect n-3 PUFA in blood fractions during linseed oil supplementation: a controlled human intervention study

Annemarie Grindel, Frank Staps, Katrin Kuhnt, Annemarie Grindel, Frank Staps, Katrin Kuhnt

Abstract

Background: Adequate biomarkers for the dietary supply of fatty acids (FA) are FA of adipose tissue and blood fractions. In human studies, invasive sample collection is unpleasant for subjects. In contrast, cheek cell sampling can be considered as a non-invasive alternative to investigate FA status.The aim of this study was to analyze whether cheek cell FA composition reflect the supplementation of alpha-linolenic acid (ALA) using a linseed oil mixture compared to olive oil supplementation. Additionally, it was investigated if cheek cell FA composition correlates with the FA composition of plasma, red blood cells (RBC) and peripheral blood mononuclear cells (PBMC) before and during both interventions.

Methods: During a 10-week randomized, controlled, double-blind human intervention study, 38 subjects provided cheek cell and blood samples. After a two-week run-in period, the test group (n = 23) received 17 g/d of an ALA-rich linseed oil mixture, while the control group (n = 15) received 17 g/d of an omega-3 (n-3) polyunsaturated FA (PUFA)-free olive oil. Cheek cells and blood were collected on days 0, 7 and 56 of the 8-week intervention period.

Results: Compared to olive oil, the linseed oil intervention increased ALA and also the endogenously converted long-chain n-3 metabolites eicosatetraenoic-, eicosapentaenoic- and docosapentaenoic acid in cheek cells (P ≤ 0.05). Docosahexaenoic acid remained unchanged. Reflecting the treatment, the n-6/n-3 ratio decreased in the test group. In general, cheek cell FA reflected the changes of FA in blood fractions. Independent of treatment, significant correlations (P ≤ 0.05) of n-6 PUFA and n-3 PUFA between cheek cells and plasma, RBC and PBMC were found, except for linoleic acid and ALA.

Conclusions: The changes in FA composition of cheek cells confirmed that ALA from linseed oil increased endogenously derived n-3 PUFA in cheek cell lipids. These changes in cheek cells and their correlation to the respective FA in blood fractions indicate the cheek cell FA profile as an adequate non-invasive biomarker for short-term n-3 PUFA intake and metabolism. Therefore, cheek cell FA can be used in human intervention studies or large-scale epidemiological studies, especially for assessment of the n-3 PUFA status.

Trial registration: ClinicalTrials.gov, IDNCT01317290.

References

    1. Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047–2067. doi: 10.1016/j.jacc.2011.06.063.
    1. Siegel G, Ermilov E. Omega-3 fatty acids: Benefits for cardio-cerebro-vascular diseases. Atherosclerosis. 2012;225:291–295. doi: 10.1016/j.atherosclerosis.2012.09.006.
    1. Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75:645–662.
    1. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PWF, Wolf PA. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease - The Framingham heart study. Arch Neurol. 2006;63:1545–1550. doi: 10.1001/archneur.63.11.1545.
    1. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics. 2003;111:6. doi: 10.1542/peds.111.1.6.
    1. Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003;133:925S–932S.
    1. Harris WS. Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factor. Pharmacol Res. 2007;55:217–223. doi: 10.1016/j.phrs.2007.01.013.
    1. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47:348–380. doi: 10.1016/j.plipres.2008.03.003.
    1. Fekete K, Marosvolgyi T, Jakobik V, Decsi T. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr. 2009;89:2070S–2084S. doi: 10.3945/ajcn.2009.27230I.
    1. Hoffman DR, Birch EE, Birch DG, Uauy R. Fatty acid profile of buccal cheek cell phospholipids as an index for dietary intake of docosahexaenoic acid in preterm infants. Lipids. 1999;34:337–342. doi: 10.1007/s11745-999-0371-y.
    1. Klingler M, Klem S, Demmelmair H, Koletzko B. Comparison of the incorporation of orally administered DHA into plasma, erythrocyte and cheek cell glycerophospholipids. Br J Nutr. 2013;109:962–968. doi: 10.1017/S000711451200222X.
    1. McMurchie EJ, Margetts BM, Beilin LJ, Croft KD, Vandongen R, Armstrong BK. Dietary-induced changes in the fatty acid composition of human cheek cell phospholipids: correlation with changes in the dietary polyunsaturated/saturated fat ratio. Am J Clin Nutr. 1984;39:975–980.
    1. Gillespi GM. Renewal of buccal epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1969;27:83–89.
    1. Klingler M, Koletzko B. Novel methodologies for assessing omega-3 fatty acid status - a systematic review. Br J Nutr. 2012;107:S53–S63. doi: 10.1017/S0007114512001468.
    1. Kuhnt K, Kraft J, Moeckel P, Jahreis G. Trans-11-18:1 is effectively Delta 9-desaturated compared with trans-12-18:1 in humans. Br J Nutr. 2006;95:752–761. doi: 10.1079/BJN20051680.
    1. Handloser D, Widmer V, Reich E. Separation of phospholipids by HPTLC - An investigation of important parameters. J Liq Chromatogr R T. 2008;13:1857–1870.
    1. Kuhnt K, Kraft J, Vogelsang H, Eder K, Kratzsch J, Jahreis G. Dietary supplementation with trans-11-and trans-12-18:1 increases cis-9, trans-11-conjugated linoleic acid in human immune cells, but without effects on biomarkers of immune function and inflammation. Br J Nutr. 2007;97:1196–1205. doi: 10.1017/S0007114507685183.
    1. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497–509.
    1. Sampugna J, Light L, Enig MG, Jones DY, Judd JT, Lanza E. Cheek cell fatty acids as indicators of dietary lipids in humans. Lipids. 1988;23:131–136. doi: 10.1007/BF02535293.
    1. Connor SL, Zhu N, Anderson GJ, Hamill D, Jaffe E, Carlson J, Connor WE. Cheek cell phospholipids in human infants: a marker of docosahexaenoic and arachidonic acids in the diet, plasma, and red blood cells. Am J Clin Nutr. 2000;71:21–27.
    1. Koletzko B, Knoppke B, von Schenck U, Demmelmair H, Damli A. Noninvasive assessment of essential fatty acid status in preterm infants by buccal mucosal cell phospholipid analysis. J Pediatr Gastroenterol Nutr. 1999;29:467–474. doi: 10.1097/00005176-199910000-00018.
    1. Laitinen K, Sallinen J, Linderborg K, Isolauri E. Serum, cheek cell and breast milk fatty acid compositions in infants with atopic and non-atopic eczema. Clin Exp Allergy. 2006;36:166–173. doi: 10.1111/j.1365-2222.2006.02417.x.
    1. Browning LM, Walker CG, Mander AP, West AL, Madden J, Gambell JM, Young S, Wang L, Jebb SA, Calder PC. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr. 2012;96:748–758. doi: 10.3945/ajcn.112.041343.
    1. Kirby A, Woodward A, Jackson S, Wang Y, Crawford MA. The association of fatty acid deficiency symptoms (FADS) with actual essential fatty acid status in cheek cells. Prostaglandins Leukot Essent Fatty Acids. 2010;83:1–8. doi: 10.1016/j.plefa.2010.02.035.
    1. Klingler M, Demmelmair H, Koletzko B, Glaser C. Fatty acid status determination by cheek cell sampling combined with methanol-based ultrasound extraction of glycerophospholipids. Lipids. 2011;46:981–990. doi: 10.1007/s11745-011-3576-7.
    1. Osswald K, Mittas A, Glei M, Pool-Zobel BL. New revival of an old biomarker: characterisation of buccal cells and determination of genetic damage in the isolated fraction of viable leucocytes. Mutat Res. 2003;544:321–329. doi: 10.1016/j.mrrev.2003.06.008.
    1. Lapillonne A, DeMar JC, Nannegari V, Heird WC. The fatty acid profile of buccal cheek cell phospholipids is a noninvasive marker of long-chain polyunsaturated fatty acid status in piglets. J Nutr. 2002;132:2319–2323.
    1. Burdge GC. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot Essent Fatty Acids. 2006;75:161–168. doi: 10.1016/j.plefa.2006.05.013.
    1. Skeaff CM, McLachlan K, Eyles H, Green T. Buccal cells as biomarkers of fat intake. Asia Pac J Clin Nutr. 2003;12(Suppl):55.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться